AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TELIX PHARMACEUTICALS LTD

15.720

-0.430-2.66%

Volume:2.53M

Turnover:40.13M

Market Cap:5.32B

PE:114.48

High:16.300

Open:16.300

Low:15.700

Close:16.150

52wk High:18.220

52wk Low:8.260

Shares:338.72M

Float Shares:275.41M

Volume Ratio:1.21

T/O Rate:0.92%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.137

EPS(LYR):-0.030

ROE:7.36%

ROA:2.71%

PB:7.58

PE(LYR):-517.55

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Jefferies Raises PT on Australia's Telix Pharma After Deal with ITM Isotope Technologies

Telix Wins FDA Fast Track for BiPASS Pre-Biopsy Prostate Cancer Imaging Study

Telix Pharmaceuticals - Illuccix and Gozellix Approved for Pet Imaging of Psma-Positive Prostate Cancer Lesions

THOMSON REUTERS

Telix Pharmaceuticals Limited-FDA Fast Track for Bipass Pre Biopsy Prostate Imaging

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/TLX.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","market":"AU","secType":"STK","nameCN":"TELIX PHARMACEUTICALS LTD","latestPrice":15.72,"timestamp":1790748720000,"preClose":16.15,"halted":0,"volume":2533433,"delay":0,"changeRate":-0.0266253869969039,"nameEN":"TELIX PHARMACEUTICALS LTD","floatShares":275410996,"shares":338721355,"eps":0.1373124273029839,"marketStatus":"Not Yet Opened","change":-0.43,"latestTime":"09-30 16:12:00 AEST","open":16.3,"high":16.3,"low":15.7,"amount":40128538,"amplitude":0.037152,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.1373124273029839,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1790812800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":16.15,"openAndCloseTimeList":[[1790726400000,1790748000000]],"volumeRatio":1.2116318393375947,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"TLX.AU","preClose":15.72,"auctionPrice":15.8,"auctionVolume":2182,"auctionTime":1790807280846,"referenceTime":1790764203089,"auction":1,"marketStatus":"盘前竞价","timestamp":1790807280846}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","floatShares":275410996,"roa":"2.71%","roe":"7.36%","lyrEps":-0.030374,"volumeRatio":1.2116318393375947,"shares":338721355,"dividePrice":0,"high":16.3,"amplitude":0.037152,"preClose":16.15,"low":15.7,"week52Low":8.26,"pbRate":"7.58","psRate":"4.15","week52High":18.22,"institutionHeld":0,"latestPrice":15.72,"eps":0.1373124273029839,"divideRate":0,"volume":2533433,"delay":0,"ttmEps":0.1373124273029839,"open":16.3,"prevYearClose":11.2,"prevWeekClose":15.9,"prevMonthClose":15.72,"prevQuarterClose":15.72,"fiveDayClose":16.08,"twentyDayClose":15.69,"sixtyDayClose":16.58},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-20","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787184000000,"name":null,"time":"","dateTimestamp":1787148000000,"actualEps":null},{"date":"2026-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771455600000,"name":null,"time":"","dateTimestamp":1771419600000,"actualEps":null},{"date":"2026-01-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1768777200000,"name":null,"time":"","dateTimestamp":1768741200000,"actualEps":null},{"date":"2025-08-21","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755734400000,"name":null,"time":"","dateTimestamp":1755698400000,"actualEps":null},{"date":"2025-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739919600000,"name":null,"time":"","dateTimestamp":1739883600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672178482","title":"Jefferies Raises PT on Australia's Telix Pharma After Deal with ITM Isotope Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2672178482","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672178482?lang=en_us&edition=fundamental","pubTime":"2026-10-01 03:04","pubTimestamp":1790795080,"startTime":"0","endTime":"0","summary":"BUZZ-Jefferies raises PT on Australia's Telix Pharma after deal with ITM Isotope Technologies** Jefferies upgrades price target on Telix PharmaceuticalsTLX.AXto A$32 from A$30** Last week, co said it ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL4N45M1NF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671357228","title":"Telix Wins FDA Fast Track for BiPASS Pre-Biopsy Prostate Cancer Imaging Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2671357228","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671357228?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:31","pubTimestamp":1790721117,"startTime":"0","endTime":"0","summary":"Telix wins FDA Fast Track for BiPASS pre-biopsy prostate cancer imaging studyTelix received FDA Fast Track designation for BiPASS, a Phase 3 program testing 68Ga PSMA-PET with MRI before prostate biop","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL8KhHrF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671288372","title":"Telix Pharmaceuticals - Illuccix and Gozellix Approved for Pet Imaging of Psma-Positive Prostate Cancer Lesions","url":"https://stock-news.laohu8.com/highlight/detail?id=2671288372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671288372?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:21","pubTimestamp":1790720514,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUE2DKRGG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671228833","title":"Telix Pharmaceuticals Limited-FDA Fast Track for Bipass Pre Biopsy Prostate Imaging","url":"https://stock-news.laohu8.com/highlight/detail?id=2671228833","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671228833?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:21","pubTimestamp":1790720514,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUE2DKRGG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":199,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TLX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}